Details of the Drug Formulations

General Information of Drug (ID: DMEFRTZ)

• Drug Name: Lurbinectedin Drug Info
• Synonyms: UNII-2CN60TN6ZS; 497871-47-3; 2CN60TN6ZS; Lurbinectedin [INN]; SCHEMBL16152477; DTXSID30198065; DB12674; CS-6323; HY-16293; J3.652.626B

Indication

Disease Entry	ICD 11	Status	REF
Small-cell lung cancer	2C25.Y	Approved	[1]
leukaemia	2A60-2B33	Phase 3	[2]
Ovarian cancer	2C73	Phase 3	[2]
Endometrial cancer	2C76	Phase 2	[3]
Solid tumour/cancer	2A00-2F9Z	Phase 2	[3]

• Cross-matching ID:
  PubChem CID: 57327016
  CAS Number: 497871-47-3
  TTD ID: D0V6OA
  ACDINA ID: D01230

Full List of Drug Formulations Containing This Drug

Lurbinectedin 4 mg Injection

Company	Formulation ID	FDA Description
Jazz Pharmaceuticals	F23220	Sucrose; Lactic Acid; Sodium Hydroxide

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020
• [2] ClinicalTrials.gov (NCT02421588) Clinical Trial of Lurbinectedin (PM01183) in Platinum Resistant Ovarian Cancer Patients. U.S. National Institutes of Health.
• [3] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)